MCK icon

McKesson

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 33.3%
Negative

Neutral
Seeking Alpha
19 hours ago
McKesson Corporation (MCK) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
McKesson Corporation (MCK) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
McKesson Corporation (MCK) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Neutral
Zacks Investment Research
2 days ago
3 Medical Supplies Stocks That Beat the Market Despite Macro Headwinds
Cardinal Health, McKesson, and Cencora are showing how scale, specialty focus, and execution can drive market-beating returns despite macro pressure.
3 Medical Supplies Stocks That Beat the Market Despite Macro Headwinds
Positive
Zacks Investment Research
5 days ago
Why McKesson (MCK) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why McKesson (MCK) is a Top Value Stock for the Long-Term
Negative
Zacks Investment Research
5 days ago
McKesson (MCK) Stock Slides as Market Rises: Facts to Know Before You Trade
McKesson (MCK) concluded the recent trading session at $814.63, signifying a -1.13% move from its prior day's close.
McKesson (MCK) Stock Slides as Market Rises: Facts to Know Before You Trade
Positive
Zacks Investment Research
6 days ago
Here's Why McKesson (MCK) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why McKesson (MCK) is a Strong Growth Stock
Positive
Zacks Investment Research
6 days ago
Investors Heavily Search McKesson Corporation (MCK): Here is What You Need to Know
McKesson (MCK) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Investors Heavily Search McKesson Corporation (MCK): Here is What You Need to Know
Neutral
Business Wire
7 days ago
Prudentia Sciences Announces Series A Led by McKesson Ventures, Accelerating Due Diligence for Life Sciences Dealmaking
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- #AI--Prudentia Sciences, a pioneer in AI-native due diligence for life sciences dealmaking, today announced that it has secured $20 million in Series A financing. The round was led by McKesson Ventures with participation from SignalFire. Existing investors include Iaso Ventures, Virtue and GV. This brings the company's total funding to $27 million, following a $7 million seed round in 2024. Prudentia Sciences provides an AI-native platform that enables pharma compa.
Prudentia Sciences Announces Series A Led by McKesson Ventures, Accelerating Due Diligence for Life Sciences Dealmaking
Positive
Zacks Investment Research
8 days ago
McKesson Builds Earnings Momentum on Specialty and Automation
McKesson posts a strong fiscal second quarter, lifts full-year EPS outlook, and shows how specialty growth and automation are reshaping its earnings power.
McKesson Builds Earnings Momentum on Specialty and Automation
Neutral
CNBC Television
8 days ago
Final Trades: Lockheed Martin, QXO and McKesson Corporation
CNBC's “Halftime Report” Investment Committee discuss their top stocks to watch for the second half of the day's trading session.
Final Trades: Lockheed Martin, QXO and McKesson Corporation
Neutral
Zacks Investment Research
15 days ago
Is It Worth Investing in McKesson (MCK) Based on Wall Street's Bullish Views?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Is It Worth Investing in McKesson (MCK) Based on Wall Street's Bullish Views?